-
Product Insights
NewProbable Global Transcription Activator SNF2L2 – Drugs In Development, 2024
The Probable Global Transcription Activator SNF2L2 pipeline drugs market research report outlays comprehensive information on the Probable Global Transcription Activator SNF2L2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Non-Small Cell Lung Cancer, and Solid Tumor. It also reviews key players involved in Probable Global Transcription Activator SNF2L2 targeted therapeutics development with...
-
Product Insights
NewSignal Transducer And Activator Of Transcription 6 – Drugs In Development, 2024
The Signal Transducer And Activator Of Transcription 6 pipeline drugs market research report outlays comprehensive information on the Signal Transducer And Activator Of Transcription 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Immunology, and Dermatology which include indications of Colorectal Cancer, Colon Cancer, Asthma, Idiopathic Pulmonary Fibrosis, Unspecified Immunological Disorders, Inflammation, and Atopic Dermatitis...
-
Product Insights
NewAdenosine Monophosphate Activated Protein Kinase – Drugs In Development, 2024
The Adenosine Monophosphate Activated Protein Kinase pipeline drugs market research report outlays comprehensive information on the Adenosine Monophosphate Activated Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Oncology, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, Congestive Heart Failure (Heart Failure), Diastolic Heart Failure (HFpEF), Unspecified Cancer, Triple-Negative Breast Cancer...
-
Product Insights
NewSignal Transducer And Activator Of Transcription 3 – Drugs In Development, 2024
The Signal Transducer And Activator Of Transcription 3 pipeline drugs market research report outlays comprehensive information on the Signal Transducer And Activator Of Transcription 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Gastrointestinal which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, Inflammation, Multiple Sclerosis, Alcohol Dependence,...
-
Product Insights
NewLymphocyte Activation Gene 3 Protein – Drugs In Development, 2024
The Lymphocyte Activation Gene 3 Protein pipeline drugs market research report outlays comprehensive information on the Lymphocyte Activation Gene 3 Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Immunology, and Undisclosed which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Central Nervous System, Multiple Sclerosis, Autoimmune Disorders, Rheumatoid Arthritis, and Unspecified....
-
Product Insights
NewT Lymphocyte Activation Antigen CD80 – Drugs In Development, 2024
The T Lymphocyte Activation Antigen CD80 pipeline drugs market research report outlays comprehensive information on the T Lymphocyte Activation Antigen CD80 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Central Nervous System which include indications of Solid Tumor, Gastric Cancer, Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Type 1 Diabetes (Juvenile Diabetes),...
-
Product Insights
NewPeroxisome Proliferator Activated Receptor Gamma – Drugs In Development, 2024
The Peroxisome Proliferator Activated Receptor Gamma pipeline drugs market research report outlays comprehensive information on the Peroxisome Proliferator Activated Receptor Gamma targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Oncology, Central Nervous System, and Gastrointestinal which include indications of Type 2 Diabetes, Diabetes, Oncology, Breast Cancer, Alzheimer's Disease, Parkinson's Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and...
-
Product Insights
NewPeroxisome Proliferator Activated Receptor Alpha – Drugs In Development, 2024
The Peroxisome Proliferator Activated Receptor Alpha pipeline drugs market research report outlays comprehensive information on the Peroxisome Proliferator Activated Receptor Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Ophthalmology, and Central Nervous System which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Primary Biliary Cholangitis (Primary Biliary Cirrhosis), Type 2 Diabetes, Hyperlipidemia, Dry (Atrophic)...
-
Product Insights
NewMitogen Activated Protein Kinase 1 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase 1 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Musculoskeletal Disorders, and Dermatology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Autoimmune Disorders, Osteoarthritis, Ankylosing Spondylitis (Bekhterev's Disease), and Dermatology. It also...
-
Product Insights
NewPeroxisome Proliferator Activated Receptor Delta – Drugs In Development, 2024
The Peroxisome Proliferator Activated Receptor Delta pipeline drugs market research report outlays comprehensive information on the Peroxisome Proliferator Activated Receptor Delta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Metabolic Disorders, Central Nervous System, and Musculoskeletal Disorders which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Type 2 Diabetes, Glycogen Storage...